Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 20 Neoplasm Metastasis 8 Leukemia, Myeloid, Acute 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Lymphoma, Non-Hodgkin 6 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Leukemia, Lymphocytic, Chronic, B-Cell 5 Uveal Melanoma 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Pleural Effusion, Malignant 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2

Interventions

pembrolizumab 4 Proton Therapy 3 toripalimab 1 spartalizumab 1 patritumab deruxtecan 1 osimertinib 1 mirdametinib 1 leronlimab 1 amivantamab 1 Valganciclovir 1 Radiotherapy 1 Paclitaxel 1 Lacteol 1 Interleukin-2 1 Docetaxel 1 Carboplatin 1 Blood Specimen Collection 1 Bevacizumab 1 BGB-283 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Interleukin-2 × 1 year × Clear all

NCT05307874 2025-12-24

EVICTION-2

ImCheck Therapeutics

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡